On July 31, 2012 the Bridge Project invited scientists and engineers to talk with clinicians and form interdisciplinary teams to address pressing challenges in the field of melanoma research.
Clinician presenters included:
David Fisher, MD, PhD (General Overview)
Keith Flaherty, MD (Targeted Therapy)
Alan Geller MPH, RN (Early Detection-High Risk Identification)
Jennifer Wargo, MD (Surgery)
Lyn Duncan, MD (Dermatopathology)
Steven Hodi, MD (Melanoma and Immunotherapy)